BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Genomic Health, Inc. (NASDAQ: GHDX) on Behalf of Genomic Shareholders and Encourages Genomic Investors to Contact the Firm
29 juil. 2019 16h08 HE | Bragar Eagel & Squire
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Genomic Health, Inc. (NASDAQ: GHDX) on behalf of...
TodosMedical.png
Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries
15 avr. 2019 08h00 HE | Todos Medical Ltd.
REHOVOT, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26 mars 2019 08h45 HE | Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
TodosMedical.png
Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel
22 mars 2018 08h00 HE | Todos Medical Ltd.
REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) (http://www.Todosmedical.com) today announced the results of a clinical trial recently completed at Kaplan...
3 Winners Declared in 2nd Value Investing Challenge Buyside Research Contest
30 août 2013 09h00 HE | SumZero, Inc.; The Value Investing Congress
NEW YORK, NY--(Marketwired - Aug 30, 2013) - SumZero, Inc. and The Value Investing Congress today announced the three winners in their annual competition designed to test the research skills of...